Technical Analysis for PFE - Pfizer, Inc.

Grade Last Price % Change Price Change
grade F 36.83 -0.22% -0.08
PFE closed down 0.22 percent on Monday, September 16, 2019, on 53 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Flat
See historical PFE trend table...

Date Alert Name Type % Chg
New Downtrend Bearish 0.00%
Overbought Stochastic Strength 0.00%
Down 3 Days in a Row Weakness 0.00%
Weak + Overbought Other -0.22%
Overbought Stochastic Strength -0.22%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.21%
Upper Bollinger Band Walk Strength -1.21%
Weak + Overbought Other -1.21%
Inside Day Range Contraction -1.21%
Overbought Stochastic Strength -1.21%

Older signals for PFE ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide. Its Primary Care segment offers human prescription pharmaceutical products primarily prescribed by primary-care physicians for Alzheimer's disease, cardiovascular, erectile dysfunction, genitourinary, major depressive disorder, pain, respiratory, and smoking cessation therapeutic and disease areas. The company's Specialty Care and Oncology segment provides human prescription pharmaceutical products for anti-infectives, endocrine disorders, hemophilia, inflammation, ophthalmology, pulmonary arterial hypertension, specialty neuroscience, and vaccines, as well as oncology and oncology-related illnesses. Its Established Products and Emerging Markets segment offers human prescription pharmaceutical products that have lost patent protection or marketing exclusivity in certain countries and/or regions, as well as that are sold in emerging markets, including Asia, Latin America, the Middle East, Eastern Europe, Africa, Turkey, and Central Europe. The company's Animal Health segment offers products and services to prevent and treat disease in livestock and companion animals, including anti-infectives, vaccines, parasiticides, medicinal feed additives, other pharmaceutical products, and other non-pharmaceutical products. Its Consumer Healthcare segment provides non-prescription products in therapeutic categories, such as dietary supplements, pain management, respiratory, and personal care. The company sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. has a strategic collaboration with CytomX Therapeutics, Inc. to develop and commercialize Multiple Probody drug conjugates in oncology. The company was founded in 1849 and is headquartered in New York, New York.
Health Biopharmaceutical Pharmaceutical Industry Pain Disease Medication Pharmaceutical Products Inflammation Alzheimer's Disease Neuroscience Pain Management Cnx Nifty Dietary Supplements Pulmonary Arterial Hypertension Major Depressive Disorder Hemophilia Anti Infectives Pfizer Erectile Dysfunction Glaxosmithkline Livestock Producers Cardiovascular Endocrine Disorders Lupin Limited Non Pharmaceutical Products
Is PFE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 46.47
52 Week Low 33.97
Average Volume 25,835,969
200-Day Moving Average 41.32
50-Day Moving Average 38.2918
20-Day Moving Average 35.8345
10-Day Moving Average 36.743
Average True Range 0.7764
ADX 31.57
+DI 19.2646
-DI 21.1009
Chandelier Exit (Long, 3 ATRs ) 35.4308
Chandelier Exit (Short, 3 ATRs ) 36.2992
Upper Bollinger Band 37.8657
Lower Bollinger Band 33.8033
Percent B (%b) 0.75
BandWidth 11.336561
MACD Line -0.114
MACD Signal Line -0.4877
MACD Histogram 0.3737
Fundamentals Value
Market Cap 219.05 Billion
Num Shares 5.95 Billion
EPS 1.37
Price-to-Earnings (P/E) Ratio 26.88
Price-to-Sales 4.06
Price-to-Book 3.64
PEG Ratio 2.40
Dividend 1.28
Dividend Yield 3.48%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 37.82
Resistance 3 (R3) 37.77 37.39 37.66
Resistance 2 (R2) 37.39 37.14 37.42 37.60
Resistance 1 (R1) 37.11 36.98 37.25 37.16 37.54
Pivot Point 36.73 36.73 36.80 36.76 36.73
Support 1 (S1) 36.45 36.48 36.59 36.50 36.12
Support 2 (S2) 36.07 36.32 36.10 36.06
Support 3 (S3) 35.79 36.07 36.01
Support 4 (S4) 35.84